U.S. Senator Tim Scott, a member of the Senate Health, Education, Labor and Pensions Committee, engaged in a confirmation hearing with Robert F. Kennedy, Jr., who has been nominated by President Trump to serve as Secretary of the Department of Health and Human Services (HHS). During the session, they covered topics such as the Right to Life, Sickle Cell Disease, and strategies for preventing and reducing drug shortages.
In addressing the Right to Life, Senator Scott emphasized foundational American values. He stated, “One of the beauties of our country is we have foundational documents that point us in the right direction. I think it’s the compass that shows us true north…The Declaration of Independence mentions life, liberty, and the pursuit of happiness as unalienable rights.” He reminded Mr. Kennedy of their previous discussion on this matter and reiterated his stance as a “pro-life Christian,” seeking confirmation that Kennedy’s deputies would also uphold pro-life principles.
On the topic of Sickle Cell Disease, Senator Scott highlighted ongoing efforts from the first Trump administration aimed at supporting individuals affected by this condition. He noted that HHS had invested in policies for those living with Sickle Cell Anemia and asked Mr. Kennedy if he would continue these initiatives: “Will you commit to continuing to have an individual serve in this coordinating role for sickle cell?”
Regarding drug shortages, Senator Scott expressed concerns following disruptions caused by Hurricane Helene. The hurricane severely impacted a facility responsible for producing most IV drugs in the U.S., leading to shortages nationwide. He mentioned Nephron Pharmaceuticals’ efforts in Columbia, South Carolina, to mitigate these shortages by establishing the Palmetto Line for IV production within state hospitals. Scott urged proactive measures against such shortages: “If confirmed, how will you prioritize efforts to prevent and reduce drug shortages, including for essential medicines?”
